Target intelligence / Profile preview

Long non-coding RNA 34a host gene (MIR34AHG)

Target
MIR34AHG
Molecular classification
Other (Long non-coding RNA)
01

Overview

Long non-coding RNA 34a host gene (MIR34AHG), also known as lnc34a, is a long non-coding RNA enriched in colon cancer stem cells and initiates asymmetric division by targeting the microRNA miR-34a for spatially imbalanced epigenetic silencing. lnc34a recruits the DNA methyltransferase Dnmt3a—via PHB2—and HDAC1, leading to methylation and deacetylation of the miR-34a promoter, resulting in its silencing. Its upregulation is associated with late-stage colorectal cancer, contributing to cancer stem cell self-renewal and tumor proliferation. MIR34AHG itself is not a receptor, enzyme, transporter, or classical therapeutic target; rather, it is a regulatory lncRNA influencing the tumor suppressor microRNA miR-34a and thus plays a crucial role in cancer biology[1].

Other names
lnc34aMIR34AHGlong non-coding RNA 34a host gene
02

Mechanism of action

Not applicable as a direct drug target; however, its suppression leads to increased miR-34a expression, which is tumor-suppressive[1].

03

Biological functions

Epigenetic regulation of gene expressionSilencing of microRNA miR-34a expression via recruitment of DNA methyltransferase Dnmt3a and histone deacetylase 1 (HDAC1)Initiation of asymmetric cell division in colon cancer stem cellsRegulation of cancer stem cell self-renewal and proliferation
04

Disease associations

Cancer (especially colorectal cancer stem cell regulation and proliferation)
05

Safety considerations

None documented, as it is not a therapeutically targeted molecule at present
06

Biomarkers

None currently established, but expression level of lnc34a/MIR34AHG could theoretically serve as a marker for colon cancer stem cell status or miR-34a silencing[1]

Beyond the preview

Go deeper on Long non-coding RNA 34a host gene (MIR34AHG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA 34a host gene (MIR34AHG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call